TCEB3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.6692428529459E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.29919999980466E-07 |
Normal-vs-Stage2 |
2.64110000536277E-08 |
Normal-vs-Stage3 |
7.76378961120372E-13 |
Normal-vs-Stage4 |
2.58900012539698E-10 |
Stage1-vs-Stage2 |
4.122300E-02 |
Stage1-vs-Stage3 |
4.369100E-04 |
Stage1-vs-Stage4 |
3.457200E-03 |
Stage2-vs-Stage3 |
5.906800E-01 |
Stage2-vs-Stage4 |
6.753200E-01 |
Stage3-vs-Stage4 |
9.412200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.56199530876711E-12 |
Normal-vs-AfricanAmerican |
1.64489999998629E-06 |
Normal-vs-Asian |
1.591370E-01 |
Caucasian-vs-AfricanAmerican |
8.817000E-01 |
Caucasian-vs-Asian |
2.949600E-01 |
AfricanAmerican-vs-Asian |
3.626600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.98854299482809E-13 |
Normal-vs-Female |
1.09200000042442E-07 |
Male-vs-Female |
4.520700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.202500E-04 |
Normal-vs-Age(41-60Yrs) |
5.97820000169946E-08 |
Normal-vs-Age(61-80Yrs) |
1.75615078035207E-12 |
Normal-vs-Age(81-100Yrs) |
1.13989999994679E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.118400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.123800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.781400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.260300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.004040E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.247600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.417200E-01 |
Normal-vs-Grade 2 |
8.76220000001204E-07 |
Normal-vs-Grade 3 |
1.62581059726108E-12 |
Normal-vs-Grade 4 |
3.00039992850998E-11 |
Grade 1-vs-Grade 2 |
2.055800E-02 |
Grade 1-vs-Grade 3 |
4.36630000000271E-05 |
Grade 1-vs-Grade 4 |
1.553850E-04 |
Grade 2-vs-Grade 3 |
2.34269999999093E-06 |
Grade 2-vs-Grade 4 |
2.559800E-04 |
Grade 3-vs-Grade 4 |
6.501000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.26169999962123E-07 |
Normal-vs-ccB subtype |
1.10099707129052E-11 |
ccA subtype-vs-ccB subtype |
1.204260E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.19659903786396E-11 |
Normal-vs-N1 |
6.03679999999773E-05 |
N0-vs-N1 |
3.410400E-01 |
|
|